Parexel
Parexel is a global contract research organization that provides clinical research, regulatory, and consulting services to biopharmaceutical and medical device companies to support the development and commercialization of new therapies. The company manages clinical trials, data management, pharmacovigilance, and market access activities on an outsourced basis. Parexel generates revenue through long-term service contracts and project-based fees with life sciences clients worldwide.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1982
- Headquarters
- Durham, United States of America
Parexel customers on Arbolus
Customers who reviewed Parexel
Seniority of Parexel customers
Most people who reviewed Parexel hold Director roles (52%), followed by C-Suite (38%) and Manager (10%).
- Director 52%
- C-Suite 38%
- Manager 10%
Customers sample
Employer names and spend open in the full report, along with the other 80 customers.
What 83 Arbolus experts think of Parexel
Overall sentiment: Positive
Parexel displays a strong NPS performance with the majority of scores at 7-10, indicating solid promoter presence and generally positive user advocacy. Renewal intent is mixed: about half signal high likelihood to renew, but a significant cohort express uncertainty, particularly among mid to high spenders. Most participants are at a more-than-a-year implementation stage, reflecting deep engagement and operational integration. Expert themes praise regulatory expertise, global coverage, and secure automation, but highlight cost and occasional continuity concerns.
Everything 83 customers told us about Parexel.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
-7 Net Promoter Score, from 83 scored reviews- Promoters 22
- Passives 33
- Detractors 28
Praised
- Mission-Critical Regulatory Support
- Operational Efficiency and Speed
- Unique Technology + Service Ecosystem
- Advanced Automation
Criticised
- Cost Concerns
- Team Continuity
- Need for Governance
- Disruption from Autonomous AI
What Parexel customers say
Mission-Critical Regulatory Support
“I rely on Parexel when scalable global support and specialist regulatory expertise are needed across multiple markets, especially for complex programs.”
Operational Efficiency and Speed
“Parexel’s automation reduced programming cycle times and expedited regulatory submission generation by up to 60%, enabling us to meet regulatory milestones faster.”
Unique Technology + Service Ecosystem
“I recommend Parexel for its ability to fuse advanced automation with clinical services, ensuring compliance and solving the data accuracy challenges that generic solutions struggle with.”
Renewal intent
Plan to renew 23%Plan to renew, by seniority
- 26% 27 answers
- 22% 37 answers
- 17% 6 answers
- 0% 1 answer
- 7.8/10 Average score from customers who will renew
- 7.1/10 Average score from undecided customers
- 6.6/10 Average score from customers not renewing
Top alternatives
Most weighed by Parexel customersReport
For people who use Parexel
Do you use Parexel at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 83 customers of Parexel have already contributed
Takes a few minutes. Your identity stays anonymous.